Tag: Prescription Drugs
FDA Advisers Back Full Approval of Paxlovid
Panel of FDA advisers says the medication remains safe and effective for high-risk patients
Clozapine, ECT, Lithium May Prevent Suicide in Male Teens With Severe Mental Illness
Regional clozapine, ECT, and lithium treatment frequency related to lower adolescent excess suicide mortality for 15- to 19-year-olds
Lebrikizumab Effective for Adults, Teens With Atopic Dermatitis
In two phase 3 trials, lebrikizumab effective for primary outcome of IGA score of 0 or 1 and for achieving EASI-75
PEPFAR Has Scaled Up HIV ART to About 20 Million Persons Since 2004
Variability seen in viral load coverage and in viral load suppression among distinct subpopulations
ACC: Coordinated Intervention Increases Rx for Evidence-Based T2DM Therapies
Multifaceted intervention of assessment, education, and feedback increases likelihood of triple prescription fourfold over usual care
FDA Approves First Treatment for Rett Syndrome
Approval of Daybue applies to adults and children aged 2 years and older
Hydrochlorothiazide Does Not Affect Recurrence of Kidney Stones
For patients with recurrent kidney stones, no difference seen in recurrence with hydrochlorothiazide 12.5, 25, 50 mg versus placebo
Nirogacestat Beneficial for Progressing Desmoid Tumors
Significant progression-free survival benefit seen over placebo; more patients receiving nirogacestat have objective response
Viral, Symptom Rebound Common After COVID-19 Infection
Incidence of symptom rebound was higher in the nirmatrelvir plus ritonavir treatment group
Preterm Birth Drug Pulled From Market Over Lack of Effectiveness
FDA has been proposing to remove Makena from the market since October 2020, a decision appealed by the drug maker
